Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Clinical trial NCT04116320 · TERMINATED

Trial details

NCT number: NCT04116320
Sponsor: Craig L Slingluff, Jr
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Breast Cancer Merkel Cell Carcinoma Squamous Cell Cancer Non Small Cell Lung Cancer Cervical Cancer Urothelial Carcinoma Ovarian Cancer Hepatocellular Carcinoma Small-cell Lung Cancer Microsatellite Instability High Gastric Cancer

Start date: 2019-11-21
Primary completion: 2023-08-15
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.